Why is Lincoln Pharmaceuticals Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 10.22% and Operating profit at 0.54% over the last 5 years
2
Flat results in Sep 26
- OPERATING PROFIT TO NET SALES (Q) Lowest at 12.38%
- PBT LESS OI(Q) Lowest at Rs 19.49 cr.
3
Stock is technically in a Mildly Bearish range
- Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
4
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
5
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -3.82% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Lincoln Pharma. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Lincoln Pharma.
-3.82%
-0.09
43.63%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
10.22%
EBIT Growth (5y)
0.54%
EBIT to Interest (avg)
56.35
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.34
Sales to Capital Employed (avg)
0.96
Tax Ratio
24.30%
Dividend Payout Ratio
4.38%
Pledged Shares
0
Institutional Holding
4.57%
ROCE (avg)
20.10%
ROE (avg)
13.48%
Valuation Key Factors 
Factor
Value
P/E Ratio
11
Industry P/E
40
Price to Book Value
1.26
EV to EBIT
8.87
EV to EBITDA
7.52
EV to Capital Employed
1.39
EV to Sales
1.04
PEG Ratio
0.50
Dividend Yield
0.35%
ROCE (Latest)
15.68%
ROE (Latest)
11.94%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Movement
3What is working for the Company
DEBTORS TURNOVER RATIO(HY)
Highest at 4.39 times
NET SALES(Q)
Highest at Rs 191.35 cr
-3What is not working for the Company
OPERATING PROFIT TO NET SALES (Q)
Lowest at 12.38%
PBT LESS OI(Q)
Lowest at Rs 19.49 cr.
Loading Valuation Snapshot...
Here's what is working for Lincoln Pharma.
Net Sales - Quarterly
Highest at Rs 191.35 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Debtors Turnover Ratio- Half Yearly
Highest at 4.39 times
in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Lincoln Pharma.
Operating Profit Margin - Quarterly
Lowest at 12.38%
in the last five quartersMOJO Watch
Company's efficiency has deteriorated
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 19.49 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 19.49 cr has Fallen at -9.68%
Year on Year (YoY)MOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)